Amerinet partners with more than 27,000 healthcare providers nationwide to reduce costs and improve quality. This agreement makes BK Medical’s surgical ultrasound systems, related accessories, and supplies available
The Phase I intravenous (IV) trial involves treatment of patients with advanced, metastatic solid tumors refractory to standard therapy. Patients receive treatment at one of five dose levels
Syringes from Catalent’s Brussels facility will likely be dispensed to patients in the US in upcoming months. Richard Yarwood, group president of Catalent’s sterile technologies segment, said: “We
The second AZ-004 Phase III clinical trial was initiated in July 2008 with a target enrollment of 300 patients, 314 patients were enrolled and Alexza expects to announce
The study will be conducted at the Winnipeg Clinic under the guidance of principal investigator, urologist, Patrick Cho. Samples collected from the study will be tested using recently
iSONEP is the ocular formulation of a monoclonal antibody that targets sphingosine-1-phosphate (S1P), a bioactive lipid that is dysregulated in cancer and other disorders of inappropriate angiogenesis and
The new broad agreement aims to deepen the already long-standing relationship between Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) and WuXi PharmaTech. WuXi, already a preferred research
The financing was led by new investor New Enterprise Associates (NEA), a global healthcare and technology venture capital firm, with additional new participation from Kaiser Permanente Ventures, an
The appointment increases the board to six members, five of whom are non-employee directors. Mr Brooksby is currently CFO of InNexus Biotechnical, a publicly traded drug development company.
Echo’s Symphony transdermal continuous glucose monitoring (tCGM) system is in late-stage development for both the diabetes home use and hospital critical care settings. Symphony incorporates Echo’s new Prelude
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.